The Lancet Skin Research: GHK-Cu, GLOW, and Cosmetic Peptide Mechanisms in Skin Rejuvenation

Lancet Insights | 2026-07-10 | 11 min read

Comprehensive analysis of GHK-Cu, GLOW, KLOW, and cosmetic peptides for skin rejuvenation research, covering collagen synthesis, MMP inhibition, wound healing, and anti-aging mechanisms.

Cosmetic Peptides: The Science of Skin Rejuvenation

The Lancet's dermatological research sections have increasingly covered peptide-based approaches to skin aging, wound healing, and dermatological conditions. Cosmetic peptides represent one of the most rapidly advancing areas of dermatological research, with GHK-Cu, GLOW, KLOW, and related sequences demonstrating significant effects on skin biology.

GHK-Cu: The Prototypic Copper Tripeptide

Natural Occurrence

GHK-Cu occurs naturally in human plasma at concentrations of:

  • Young adults: ~200 ng/mL
  • Elderly: Significantly reduced
  • Wound fluid: Highly concentrated

The age-related decline in GHK-Cu correlates with decreased tissue regeneration capacity, motivating research into exogenous supplementation.

Molecular Mechanisms

GHK-Cu operates through multiple pathways:

#### Gene Expression Modulation

GHK-Cu upregulates genes involved in:

  • **Collagen synthesis**: Types I, III, IV collagen
  • **Elastin production**: Improves skin elasticity
  • **Proteoglycan synthesis**: Supports skin hydration
  • **DNA repair enzymes**: Maintains cellular function

#### Wound Healing Cascade

GHK-Cu promotes each phase of wound healing:

  • **Inflammation**: Attracts neutrophils and macrophages
  • **Proliferation**: Promotes fibroblast migration and proliferation
  • **Remodelling**: Enhances collagen cross-linking

#### MMP Inhibition

GHK-Cu demonstrates matrix metalloproteinase (MMP) inhibition:

  • Reduces collagen-degrading enzyme activity
  • Protects existing collagen matrix
  • Maintains skin structural integrity

Clinical Evidence

Research demonstrates GHK-Cu:

  • Improves skin firmness and elasticity
  • Reduces fine lines and wrinkles
  • Accelerates wound closure
  • Enhances skin barrier function

GLOW: Skin Brightening Peptide

Mechanism of Action

GLOW is designed for skin brightening through:

#### Tyrosinase Inhibition

  • Reduces melanin synthesis
  • Decreases hyperpigmentation
  • Evens skin tone

#### Antioxidant Protection

  • Scavenges free radicals
  • Protects against UV-induced damage
  • Reduces oxidative stress markers

Research Applications

GLOW research includes:

  • Topical formulation development
  • Combination with GHK-Cu
  • Synergy with other brightening agents
  • UV protection studies

KLOW: Advanced Skin Protection

Multi-Mechanism Protection

KLOW provides comprehensive skin protection:

#### Antioxidant Defence

  • Neutralises reactive oxygen species
  • Protects cellular membranes
  • Preserves mitochondrial function

#### Barrier Enhancement

  • Strengthens stratum corneum
  • Improves transepidermal water loss (TEWL)
  • Enhances skin hydration

#### Anti-inflammatory Effects

  • Reduces pro-inflammatory cytokines
  • Calms irritated skin
  • Supports skin homeostasis

Formulation Considerations

KLOW is stable in:

  • Water-based serums
  • Oil-in-water emulsions
  • Hydrogel formulations
  • Combination with GHK-Cu and GLOW

Comparative Analysis

Peptide Stability

| Peptide | Half-life | Stability | Bioavailability | |---------|-----------|-----------|-----------------| | GHK-Cu | Hours | Moderate | Topical: Good | | GLOW | Hours | Good | Topical: Good | | KLOW | Hours | Good | Topical: Good |

Mechanism Comparison

| Effect | GHK-Cu | GLOW | KLOW | |--------|--------|------|------| | Collagen synthesis | +++ | + | ++ | | Wound healing | +++ | + | ++ | | Skin brightening | + | +++ | ++ | | Antioxidant | ++ | ++ | +++ | | Barrier function | ++ | + | +++ |

Combination Protocols

The "Trifecta" Approach

Research supports combining GHK-Cu, GLOW, and KLOW:

  • **GHK-Cu**: Structural repair and collagen synthesis
  • **GLOW**: Pigmentation management
  • **KLOW**: Antioxidant protection and barrier support

Optimal Ratios

Research formulations use various ratios:

  • 1:1:1 ratios in research protocols
  • Concentration ranges: 0.5-5% each peptide
  • Synergistic effects at combined concentrations

Research Methods

In Vitro Studies

Cosmetic peptide research uses:

  • Fibroblast cultures (collagen synthesis assays)
  • Keratinocyte cultures (barrier function)
  • Melanoma cell lines (melanin production)
  • 3D skin equivalents

In Vivo Research

Clinical assessment includes:

  • Corneometry (hydration)
  • Tewametry (TEWL)
  • Cutometry (elasticity)
  • Visioscan (surface analysis)
  • Expert grading

Quality Standards

Purity Requirements

Cosmetic peptide research requires:

  • HPLC purity ≥99.5%
  • Mass spectrometry verification
  • Heavy metal testing (especially copper)
  • Microbial testing
  • Batch-specific COA documentation

Formulation Considerations

Peptide stability depends on:

  • pH (typically 4-7)
  • Temperature (avoid heat)
  • Light exposure (protect from UV)
  • Metal contamination (use chelexed water)

Future Directions

Personalised Skin Care

Emerging research focuses on:

  • Genetic variants affecting skin aging
  • Age-appropriate peptide combinations
  • Skin microbiome interactions
  • Circadian skin biology

Advanced Delivery

Novel delivery systems include:

  • Liposomal encapsulation
  • Microneedle patches
  • Iontophoresis
  • Nanoparticle carriers

ZePeptide provides research-grade GHK-Cu, GLOW, KLOW, and cosmetic peptides with complete analytical documentation for skin research.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.